Duncker Streett & Co’s Biogen BIIB Stock Holding History

Duncker Streett & Co’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20	Closed	-$5K	–	596
2018 Q1	$5K	Hold	20	–	–	﹤0.01%	548
2017 Q4	$6K	Hold	20	–	–	﹤0.01%	534
2017 Q3	$6K	Hold	20	–	–	﹤0.01%	538
2017 Q2	$5K	Hold	20	–	–	﹤0.01%	563
2017 Q1	$5K	Buy	+20	New	+$5.66K	﹤0.01%	574
2015 Q2	–	Sell	-100	Closed	-$42K	–	623
2015 Q1	$42K	Hold	100	–	–	0.01%	401
2014 Q4	$34K	Hold	100	–	–	0.01%	416
2014 Q3	$33K	Hold	100	–	–	0.01%	416
2014 Q2	$32K	Hold	100	–	–	0.01%	429
2014 Q1	$31K	Buy	+100	New	+$31.7K	0.01%	416

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Duncker Streett & Co's BIIB Position: Q2 2018 in Review

Duncker Streett & Co sold out of Biogen (BIIB) in Q2 2018, closing a stake of 20 shares — an estimated $5K sold.

Duncker Streett & Co first reported a position in BIIB in Q1 2014 and held it in 10 quarters. The position peaked at $42K in Q1 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Duncker Streett & Co reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Duncker Streett & Co sold 20 Biogen shares in Q2 2018, an estimated $5K.
Duncker Streett & Co first reported a position in Biogen in Q1 2014 and held it in 10 quarters.
Duncker Streett & Co's Biogen position peaked at $42K in Q1 2015.
1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Duncker Streett & Co's 13F filing for Q2 2018, filed 23 Jul 2018.